Proteon Therapeutics, Inc.
200 West Street
Waltham, MA 02451
December 18, 2019
VIA EDGAR AND E-MAIL
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Joseph McCann
Re: Proteon Therapeutics, Inc. Registration Statement on Form S-4 (File No. 333-234549)
Ladies and Gentlemen:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-4 (File No. 333-234549) (the “Registration Statement”) of Proteon Therapeutics, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:00 p.m., Eastern time, on December 19, 2018, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Morgan, Lewis & Bockius LLP, by calling Tara McElhiney at (713) 890-5732.
[Remainder of page intentionally left blank]
|
|
Very truly yours, | |
|
|
| |
|
|
Proteon Therapeutics, Inc. | |
|
|
|
|
|
|
By: |
/s/ George Eldridge |
|
|
|
George Eldridge, |
|
|
|
Senior Vice President, Chief Financial Officer, Treasurer and Assistant Secretary |
|
CC: |
Timothy P. Noyes, Proteon Therapeutics, Inc. |
|
|
Julio E. Vega, Morgan, Lewis & Bockius LLP |
|
|
Tara R. McElhiney, Morgan, Lewis & Bockius LLP |
|
|
Zachary E. Zemlin, Morgan, Lewis & Bockius LLP |
[Proteon Therapeutics, Inc. – Signature Page to Request for Acceleration]